Trial Details
COMPLETEDBasic Information
| Clinical ID | c1163 |
|---|---|
| Identifier | NCT05482464 |
| Trial Title | Effect of Daily Consumption of Glycomacropeptide on Gut Microbiome and Blood Functional Proteome of Subjects With Irritable Bowel Syndrome |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Syndrome |
| Interventions | DIETARY_SUPPLEMENT: Casein glycomacropeptide (CGMP) |
Participant Information
| Sponsor | Oregon State University |
|---|---|
| City | Corvallis |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2022-01-01 |
|---|---|
| Primary Completion Date | 2024-09-01 |
| Completion Date | 2024-09-01 |